Showing results (41-50 of 227) with videos related to
Sort By:
Pageof 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Protracted drug infusions in cancer treatment: an appraisal of 5-fluorouracil, doxorubicin, and platinumsE DelaFlor-Weiss, B Uziely, F M MuggiaHead & Neck Surgery|January 1, 1980
Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced diseaseF M Muggia, M Rozencweig, A E LouieAnnals of the New York Academy of Sciences|December 13, 1996
Camptothecin and its analogs. An overview of their potential in cancer therapeuticsF M Muggia, I Dimery, S G ArbuckRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The rediscovery of DON (6-diazo-5-oxo-L-norleucine)D L Kisner, R Catane, F M MuggiaCancer|April 1, 1977
Adjuvant chemotherapy in lung cancer: review and prospectsS S Legha, F M Muggia, S K CarterCancer Treatment Reports|June 1, 1983
Kaposi's sarcoma: a new staging classificationR L Krigel, L J Laubenstein, F M MuggiaCancer Treatment Reports|January 1, 1981
Future clinical investigations with anthracycline antibiotics in relation to daunorubicinF M Muggia, R H Blum, J C WernzAnnals of Internal Medicine|August 1, 1976
5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemiaD D Von Hoff, M Slavik, F M MuggiaAnti-Cancer Drugs|January 7, 1999
Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: tolerance and activity in ovarian cancerT Safra, S Jeffers, J Sorich, et al.Anticancer Research|July 1, 1988
A new look at radionuclides therapy in metastatic disease of bone (review and prospects)S I Kim, D C Chen, F M MuggiaPageof 23